Journal of Drugs in Dermatology

View more issues:

Articles in Oct, 2003 issue of Journal of Drugs in Dermatology

• Photodynamic therapy with topical aminolevulinic acid and pulsed dye laser irradiation for sebaceous hyperplasia
  by Tina S Alster
• Using rituximab in a patient with paraneoplastic pemphigus
  by Monica B Schadlow
• A practical technique for differentiation of sub-epidermal bullous diseases: localization of in vivo-bound IGG by laser scanning confocal microscopy
  by K Wozniak
• Interleukin-12 gene therapy in treating patients with skin metastases
• To study disease relapse after NBUVB and how the administration of daclizumab/placebo alters disease relapse
• Phase II study of ultraviolet A-1 light therapy for systemic lupus erythematosus
• Interleukin-12 with either liposomal doxorubicin or 96 hour continuous infusion paclitaxel in AIDS-associated kaposi's sarcoma followed by chronic administration of interleukin-12
• Open label study of ONTAK® in previously treated cutaneous T-cell lymphoma patients
• Errata., 378-383, 2003
  by Eric S. Schweiger
• Yellow nail pigmentation following depakote therapy
  by Robert Buka
• Updated labeling for Soriatane for psoriasis
• Photodynamic therapy in treating patients with skin cancer
• ZD1839 for recurrent or metastatic squamous cell carcinoma of the skin
• Celecoxib in preventing basal cell carcinoma in patients with basal cell nevus syndrome
• Aldara™ Cream to treat basal cell carcinoma
• Cancer vaccine for lymphoma following chemotherapy
• Non-surgical radiofrequency facelift
  by David J Narins
• Morbilliform drug reaction with histologic features of pustular dermatosis associated with bryostatin-1
  by Jennifer M Krejci-Manwaring
• The nonrandom distribution of facial hemangiomas
  by Milton Waner
• Photodynamic therapy in treating patients with basal cell skin cancer
• To study the use of humanized CD25 in preventing the relapse of psoriasis vulgaris
• Radiation therapy in preventing metastatic cancer in patients who have diagnostic procedures to identify malignant mesothelioma
• Peptide vaccination for patients at high risk for recurrent melanoma
• Etanercept to treat Wegener's granulomatosis
• Skin cancer sites online: watch out for red flags
• 75 mg Adoxa tablets available in U.S
• Determine the efficacy of topical tretinoin cream the prevention of nonmelanoma skin cancer
• Bioengineered skin and wound healing
• Vaccine therapy followed by biological in treating patients with stage III or stage IV melanoma
• Study of GL701 in men with systemic lupus erythematosus
• Gp100 and MDX-CTLA-4 vaccination for stage IV melanoma
• A letter from the guest editor
  by Rhoda S. Narins
• Nephrogenic fibrosing dermopathy after five days of hemodialysis
  by John G Hancox
• Assessment of adapalene gel for the treatment of actinic keratoses and lentiginess a randomized trial
  by S Kang
• Phase II randomized study of cultured skin substitutes versus split thickness skin grafts in patients with severe burn injuries
• Photodynamic therapy in treating patiens with skin cancer
• Oral type I collagen in scleroderma
• Campath-1H for treating adult T-cell leukemia
• Depsipeptide to treat T-cell lymphomas
• Long term sterility of fat frozen for up to 24 months
  by Rhoda S Narins
• Multiple fixed drug eruption with interferon/ribavirin combination therapy for hepatitis c virus infection
  by Navjeet K Sidhu-Malik
• Efficacy and safety of azelaic acid gel as a new treatment for papulopustular rosacea: results from two vehicle-controlled, randomized phase III studies
  by Diane Thiboutot
• Two studies to determine if verteporfin PDT is effective & safe in treating multiple basal cell carcinomas of the skin
• Phase II trial of allovectin-7® for metastatic melanoma
• Long-term treatment and re-treatment of lower extremity diabetic ulcers with Regranex® or placebo
• Tyrosinase-related protein vaccination for metastatic melanoma
• Randomized double-blind study of ONTAK® in cutaneous T-cell lymphoma patients
• Their role in dermatology practice
  by Neil S Sadick
• FDA recommends approval of Enbrel for the treatment of ankylosing spondylitis
• Celocoxib in preventing skin cancer in patients with actinic keratoses
• Topical imiquimod compared with surgery in treating patients with basal cell skin cancer
• Oral acyclovir for neonatal HSV disease of the skin, eyes, and mouth
• Phase I study of immune ablation and CD34+ peripheral blood stem cell support in patients with systemic lupus erythematosus
• IL-2 gene therapy for metastatic melanoma
• Enhancement of the results of neck liposuction with the family technique
  by Kimberly J Butterwick
• Rosacea fulminans associated with pegylated interferon alpha-2b and ribavirin theraphy
  by Sarah L. Jensen
• Treating Bowen's disease: a cost-minimization study
  by VS Ramrakha-Jones
• Photodynamic therapy in treating patients with skin cancer or solid tumors metastatic to the skin
• To study the effects of CD25 and low-dose cyclosporin in the treatment of active psoriasis Vulgaris
• Study of Remodulin in patients with critical limb ischemia with no planned revascularization procedures
• Stem cell transplant therapy with campath-1H for treating advanced mycosis fungoides and sezary syndrome
• PS-341 alone and PS-341 plus EPOCH chemotherapy to treat non-Hodgkin's lymphoma
• Phosphatidylcholine in the treatment of localized fat
  by Doris Hexsel
• New FDA indication for Humatrope
• Paroxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trial
  by V Stearns
• Celoxib in preventing skin cancer
• Morphine gel for bedsores
• Phase II study of high-dose cycloposphamide in patients with refractory pemphigus
• Vaccine plus interleukin-2 treatment of metastatic melanoma
• Treatment of hyperhidrosis
  by Lewis P Stolman
• FDA approves Enbrel for treatment of rheumatoid arthritis
• Suggested guidelines for screening and management of tuberculosis in patients taking oral glucocorticoids—an important but often neglected issue
  by Y.C. Chan
• Phase III randomized study of oral acyclovir in infants with herpes simplex virus infection limited to skin, eyes, and mouth
• PHASE III randomized study of oral acyclovir in infants with herpes simplex virus infection involving the central nervous system
• Determine the effect of administering Periostat® twice daily on patients with acne rosacea
• CTLA-4 antibody plus interleukin-2 to treat advanced melanoma